Reaction Details Report a problem with these data
Target
Tyrosine-protein kinase JAK2 [536-812,V617F,W659A,W777A,F794H]
Ligand
BDBM604317
Substrate
n/a
Meas. Tech.
JAK2 LanthaScreen JH2-V617F Binding Assay
IC50
<100±n/a nM
Citation
 Liu, K; Douty, B; Levy, D; Wu, L; Yao, W; Yue, EW Tricyclic urea compounds as JAK2 V617F inhibitors US Patent  US11661422 Publication Date 5/30/2023 
Target
Name:
Tyrosine-protein kinase JAK2 [536-812,V617F,W659A,W777A,F794H]
Synonyms:
JAK2 | JAK2_HUMAN | Tyrosine-protein kinase JAK2 JH2 (536-812) V617F
Type:
Enzyme Catalytic Domain
Mol. Mass.:
31802.68
Organism:
Homo sapiens (Human)
Description:
aa 536-812 V617F
Residue:
277
Sequence:
VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD
  
Inhibitor
Name:
BDBM604317
Synonyms:
4-(9-(4-(1- Aminocyclopropyl) phenyl)-4-methyl-8-(4-((4- (methylsulfonyl)piperidin- 1-yl)methyl)phenyl)-3- oxo-1,3,4,7-tetrahydro- 2H-pyrrolo[3',2':5,6] pyrido[3,4-d] pyrimidin-2-yl)benzoic acid trifluoroacetic acid salt (1:2) | US11661422, Example 21
Type:
Small organic molecule
Emp. Form.:
C39H40N6O5S
Mol. Mass.:
704.837
SMILES:
CN1C(=O)N(Cc2c1cnc1[nH]c(c(-c3ccc(cc3)C3(N)CC3)c21)-c1ccc(CN2CCC(CC2)S(C)(=O)=O)cc1)c1ccc(cc1)C(O)=O
Structure:
Search PDB for entries with ligand similarity: